Your browser doesn't support javascript.
loading
Design and Synthesis of Multi-Functional Ligands through Hantzsch Reaction: Targeting Ca2+ Channels, Activating Nrf2 and Possessing Cathepsin S Inhibitory, and Antioxidant Properties.
Pachón-Angona, Irene; Bernard, Paul J; Simakov, Alexey; Maj, Maciej; Jozwiak, Krzysztof; Novotna, Anna; Lemke, Carina; Gütschow, Michael; Martin, Helene; Oset-Gasque, María-Jesús; Contelles, José-Marco; Ismaili, Lhassane.
Afiliação
  • Pachón-Angona I; Université de Franche-Comté, UMR INSERM 1322 LINC, F-25000 Besançon, France.
  • Bernard PJ; Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Complutense University of Madrid, Plaza Ramón y Cajal s/n, Ciudad Universitaria, 28040 Madrid, Spain.
  • Simakov A; Université de Franche-Comté, UMR INSERM 1322 LINC, F-25000 Besançon, France.
  • Maj M; Université de Franche-Comté, EFS, INSERM, UMR RIGHT, F-25000 Besançon, France.
  • Jozwiak K; Department of Biopharmacy, Medical University of Lublin, ul. W. Chodzki 4a, 20-093 Lublin, Poland.
  • Novotna A; Department of Biopharmacy, Medical University of Lublin, ul. W. Chodzki 4a, 20-093 Lublin, Poland.
  • Lemke C; Pharmaceutical Institut, An der Immenburg 4, D-53121 Bonn, Germany.
  • Gütschow M; Pharmaceutical Institut, An der Immenburg 4, D-53121 Bonn, Germany.
  • Martin H; Pharmaceutical Institut, An der Immenburg 4, D-53121 Bonn, Germany.
  • Oset-Gasque MJ; Université de Franche-Comté, EFS, INSERM, UMR RIGHT, F-25000 Besançon, France.
  • Contelles JM; Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Complutense University of Madrid, Plaza Ramón y Cajal s/n, Ciudad Universitaria, 28040 Madrid, Spain.
  • Ismaili L; Instituto Universitario de Investigación en Neuroquímica, Complutense University of Madrid, Ciudad Universitaria, 28040 Madrid, Spain.
Pharmaceutics ; 16(1)2024 Jan 17.
Article em En | MEDLINE | ID: mdl-38258131
ABSTRACT
This work relates to the design and synthesis of a series of novel multi-target directed ligands (MTDLs), i.e., compounds 4a-l, via a convenient one-pot three-component Hantzsch reaction. This approach targeted calcium channel antagonism, antioxidant capacity, cathepsin S inhibition, and interference with Nrf2 transcriptional activation. Of these MTDLs, 4i emerged as a promising compound, demonstrating robust antioxidant activity, the ability to activate Nrf2-ARE pathways, as well as calcium channel blockade and cathepsin S inhibition. Dihydropyridine 4i represents the first example of an MTDL that combines these biological activities.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Pharmaceutics Ano de publicação: 2024 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Pharmaceutics Ano de publicação: 2024 Tipo de documento: Article País de afiliação: França